Company: CDT
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001641172-25-006259
Chunk: 2

Company: CDT Equity Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 2
---
 proxy issued in your name from that record holder.

| 1 |

<div align='center'>4581 Tamiami Trail North, Suite 200

Naples, Florida 34103

(646) 491-9132

PROXY STATEMENT</div>

Conduit Pharmaceuticals Inc.
is furnishing this proxy statement to our stockholders of record as of the close of business on April 21, 2025 (the “Record Date”)
in connection with our solicitation of proxies for use at the virtual special meeting of stockholders to be held on Monday, May 5, 2025
at 10:00 a.m., Eastern Time and any adjournment(s), postponement(s) or other delays thereof (the “Special Meeting”).

The Special Meeting will
be a completely “virtual” meeting of stockholders. You will be able to listen and participate in the virtual special meeting
as well as vote and submit your questions during the live webcast of the meeting by registering in advance of the Special Meeting at https://meeting.vstocktransfer.com/CONDUITMAY25.
A Zoom account is required to register. If your shares are held by a bank, broker or other agent, please follow the instructions from
your bank, broker or other agent to have your shares voted.

References in this proxy
statement to the “Company,” “we,” “us,” “our” and similar terms mean Conduit Pharmaceuticals
Inc.

The accompanying proxy is
solicited by our Board of Directors (our “Board”) and is revocable by you at any time before it is voted at the Special Meeting,
as described below.

Our principal executive offices
are located at 4581 Tamiami Trail North, Suite 200, Naples, Florida, 34103, and our telephone number is (646) 491-9132.

Who May Vote

Only holders of
our common stock, par value $0.0001 (the “Common Stock”), outstanding as of the close of business on the Record Date are
entitled to receive notice of, and to vote at, the Special Meeting. As of the Record Date, there were 11,338,523 shares of Common Stock
outstanding and entitled to vote at the Special Meeting and there were no other classes of securities outstanding that will be entitled
to vote at the Special Meeting. Each share of Common Stock is entitled to one vote on the proposal to be voted on by the holders of
Common Stock entitled to vote at